EUVIMEDEUVIMED entdecken
Open Access

Transglutaminase 7 Silencing Inhibits Proliferation and Modulates Inflammatory and Apoptotic Markers in Testicular Germ Cell Tumors

Rawabi S Altuwayjiri, Ibtesam S Almami

Oncology Research · 2025

DOI: 10.32604/or.2025.070104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Rawabi S Altuwayjiri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, Qassim University, Buraydah, 52571, Al-Qassim, Saudi Arabia. Hauptthemen laut MEDLINE: Transglutaminases, Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Testicular germ cell tumors (TGCTs) represent the most common malignancy among young men aged 20-40 years. Transglutaminase 7 (TG7), encoded by TGM7, is a poorly characterized enzyme whose function in TGCT remains unknown. This study aimed to assess TG7 expression in clinical specimens and investigate its functional role in a testicular germ cell tumor cell line (NT2/D1).

Methods

TG7 protein expression was evaluated in clinical testicular tissue samples via immunohistochemistry (IHC) and immunofluorescence (IF). Functional analysis was conducted in the NT2/D1 human testicular cancer cell line using Dicer-substrate small interfering RNAs (DsiRNAs) targeting TG7. Gene knockdown efficiency was confirmed by reverse transcription quantitative PCR (qRT-PCR), and protein suppression was validated by immunofluorescence. Cell viability was assessed using the MTT assay. The expression of inflammation and apoptosis-related genes was quantified via qRT-PCR.

Results

TG7 expression was significantly elevated in testicular germ cell tumor tissues, showing approximately a 4.5-fold increase compared to normal testis, with strong localization in tumor nests and stromal compartments. In NT2/D1 cells, TG7 silencing using 20 nM DsiRNA3 led to a dose-dependent reduction in cell viability, with up to 48% inhibition observed at 200 nM (MTT assay, ****p < 0.0001). qRT-PCR analysis revealed significant upregulation of IL6 (3.2-fold), TNFα (2.8-fold), and CASP3 (2.5-fold) mRNA levels following TG7 knockdown (p < 0.0001), while p53 expression remained unchanged. These findings support TG7's role in modulating tumor cell survival, inflammation, and apoptosis via p53-independent pathways.

Conclusion

Collectively, TG7 is significantly overexpressed in TGCT tissues and supports tumor cell viability in vitro. This study establishes TG7 as a novel biomarker and therapeutic target in testicular cancer, laying the groundwork for future studies on TG7-targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransglutaminasesTesticular NeoplasmsNeoplasms, Germ Cell and EmbryonalHumansMaleApoptosisCell ProliferationCell Line, TumorInflammationGene SilencingBiomarkers, TumorAdultGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Human malignantgene expressionknockdownproliferationtesticular germ cell linetransglutaminase 7

Substanzen

TransglutaminasesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biology, College of Science, Qassim University, Buraydah, 52571, Al-Qassim, Saudi Arabia.

Zitieren

APA

Altuwayjiri, R. S., & Almami, I. S. (2025). Transglutaminase 7 Silencing Inhibits Proliferation and Modulates Inflammatory and Apoptotic Markers in Testicular Germ Cell Tumors. Oncology Research. https://doi.org/10.32604/or.2025.070104

Vancouver

Altuwayjiri RS, Almami IS. Transglutaminase 7 Silencing Inhibits Proliferation and Modulates Inflammatory and Apoptotic Markers in Testicular Germ Cell Tumors. Oncology Research. 2025. doi:10.32604/or.2025.070104

BibTeX
@article{Altuwayjiri2025,
  author = {Altuwayjiri, Rawabi S and Almami, Ibtesam S},
  title = {Transglutaminase 7 Silencing Inhibits Proliferation and Modulates Inflammatory and Apoptotic Markers in Testicular Germ Cell Tumors},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.070104}
}
Kostenlos starten →